NORTHERN TRUST CORP - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$2,162,705
-9.9%
1,065,372
+2.1%
0.00%
Q2 2023$2,399,961
-16.6%
1,043,461
+9.9%
0.00%
-100.0%
Q1 2023$2,878,167
+34.5%
949,890
+3.4%
0.00%
Q4 2022$2,140,667
+24.5%
918,741
+2.0%
0.00%
Q3 2022$1,720,000
-29.2%
900,547
+0.4%
0.00%
-100.0%
Q2 2022$2,431,000
+5.4%
896,972
+15.9%
0.00%
Q1 2022$2,307,000
-19.3%
774,239
+5.4%
0.00%
Q4 2021$2,857,000
-4.9%
734,468
+4.8%
0.00%
-100.0%
Q3 2021$3,005,000
+37.9%
700,504
-2.6%
0.00%
Q2 2021$2,179,000
+393.0%
719,159
+441.9%
0.00%
Q1 2021$442,000
+9.1%
132,703
+16.2%
0.00%
Q4 2020$405,000
+8.0%
114,203
-4.6%
0.00%
Q3 2020$375,000
+99.5%
119,683
+16.4%
0.00%
Q2 2020$188,000
-69.2%
102,787
-64.9%
0.00%
Q2 2019$610,000
-45.7%
293,078
-6.6%
0.00%
Q1 2019$1,123,000
-5.7%
313,760
+0.8%
0.00%
Q4 2018$1,191,000
-62.0%
311,118
-6.2%
0.00%
-100.0%
Q3 2018$3,135,000
+44.9%
331,708
+11.9%
0.00%0.0%
Q2 2018$2,164,000296,4160.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,705,128$10,300,0004.44%
RTW INVESTMENTS, LP 5,666,754$15,754,0000.59%
COWEN AND COMPANY, LLC 926,200$2,575,0000.22%
Hudson Bay Capital Management LP 850,000$2,363,0000.05%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,774,915$4,934,0000.03%
Point72 Asset Management, L.P. 1,897,284$5,274,0000.03%
683 Capital Management, LLC 77,368$215,0000.02%
Secure Asset Management, LLC 10,000$28,0000.02%
Qube Research & Technologies Ltd 166,138$462,0000.01%
Verition Fund Management LLC 174,455$485,0000.01%
View complete list of ARBUTUS BIOPHARMA CORP shareholders